帕金森病手术患者围手术期的麻醉管理

doi:10.3969/j.issn.1006-9771.2020.11.012

摘要/Abstract

摘要：

帕金森病是一种具有运动神经学障碍和非运动神经学障碍的进展性神经退行性疾病,患者在接受手术时存在一定风险,需完善围手术期管理。本文综述帕金森病患者麻醉相关的注意事项。

Abstract:

Parkinson's disease is a neurodegenerative disorder with features of motor and non-motor disturbances. These patients are in some risks when they receive surgery, and perfect perioperatve management is needed. This paper reviewed perioperatve management related to anesthesiologists.

Key words: Parkinson's disease, surgery, anesthesia, perioperatve management, rehabilitation

中图分类号:

R742.5

熊巍,江磊综述,王强,罗芳审校. 帕金森病手术患者围手术期的麻醉管理[J]. 《中国康复理论与实践》, 2020, 26(11): 1316-1321.

XIONG Wei,JIANG Lei,WANG Qiang,LUO Fang. Perioperative Management of Anesthesia for Patients with Parkinson's Disease (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2020, 26(11): 1316-1321.

参考文献 91

[1]	Kalia L V, Lang A E. Parkinson's disease[J]. Lancet, 2015, 386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3
[2]	Lee A, Gilbert R M. Epidemiology of Parkinson disease[J]. Neurol Clin, 2016, 34(4):955-965. doi: 10.1016/j.ncl.2016.06.012
[3]	de Virgilio A, Greco A, Fabbrini G, et al. Parkinson's disease: autoimmunity and neuroinflammation[J]. Autoimmun Rev, 2016, 15(10):1005-1011. doi: 10.1016/j.autrev.2016.07.022 pmid: 27497913
[4]	Deng H, Gao K, Jankovic J. The VPS35 gene and Parkinson's disease[J]. Mov Disord, 2013, 28(5):569-575. doi: 10.1002/mds.25430
[5]	Moisan F, Kab S, Mohamed F, et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis[J]. J Neurol Neurosur Psychiatry, 2016, 87(9):952-957. doi: 10.1136/jnnp-2015-312283
[6]	Tamara P, Nathalie J, Alexandra F, et al. The prevalence of Parkinson's disease: a systematic review and meta-analysis[J]. Mov Disord, 2014, 29(13):1583-1590. doi: 10.1002/mds.25945
[7]	Oichi T, Chikuda H, Ohya J, et al. Mortality and morbidity after spinal surgery in patients with Parkinson's disease: a retrospective matched-pair cohort study[J]. Spine J, 2017, 17(4):531-537. doi: 10.1016/j.spinee.2016.10.024
[8]	Bologna M, Leodori G, Stirpe P, et al. Bradykinesia in early and advanced Parkinson's disease[J]. J Neurol Sci, 2016, 369:286-291. doi: S0022-510X(16)30519-6 pmid: 27653910
[9]	Simonet C, Tolosa E, Camara A, et al. Emergencies and critical issues in Parkinson's disease[J]. Pract Neurol, 2020, 20(1):15-25.
[10]	Samà A, Pérez-López C, Rodríguez-Martín D, et al. Estimating bradykinesia severity in Parkinson's disease by analysing gait through a waist-worn sensor[J]. Comput Biol Med, 2017, 84:114-123. doi: S0010-4825(17)30075-6 pmid: 28351715
[11]	Bravo M, Bermeo A, Huerta M, et al. A system for finger tremor quantification in patients with Parkinson's disease[J]. Conf Proc IEEE Eng Med Biol Soc, 2017, 2017:3549-3552.
[12]	Gigante A F, Pellicciari R, Iliceto G, et al. Rest tremor in Parkinson's disease: body distribution and time of appearance[J]. J Neurol Sci, 2017, 375:215-219. doi: S0022-510X(16)30850-4 pmid: 28320133
[13]	Lee H J, Lee W W, Kim S K, et al. Tremor frequency characteristics in Parkinson's disease under resting-state and stress-state conditions[J]. J Neurol Sci, 2016, 362:272-277.
[14]	Numao A, Suzuki K, Fujita H, et al. Resting and re-emergent tongue tremor in Parkinson's disease[J]. BMJ Case Reports, 2017, 2017: bcr2017221808.
[15]	Delil Ş, Bölükbaşı F, Yeni N, et al. Re-emergent tongue tremor as the presenting symptom of Parkinson's disease[J]. Balk Med J, 2015, 32(1):127-128.
[16]	Udupk K, Chen R. Motor cortical circuits in Parkinson disease and dystonia[J]. Handb Clin Neurol, 2019, 161:167-186
[17]	Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease[J]. J Neurochem, 2016, 139(Suppl 1):318-324. doi: 10.1111/jnc.13691
[18]	Moustafa A A, Chakravarthy S, Phillips J R, et al. Motor symptoms in Parkinson's disease: a unified framework[J]. Neurosci Biobehav Rev, 2016, 68(9):727-740. doi: 10.1016/j.neubiorev.2016.07.010
[19]	Landau S, Harris V, Burn D, et al. Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis[J]. Psychol Med, 2016, 46(3):657-667. doi: 10.1017/S0033291715002196 pmid: 26492977
[20]	Broen M P, Braaksma M M, Patijn J, et al. Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool[J]. Mov Disord, 2012, 27(4):480-484. doi: 10.1002/mds.24054
[21]	Sung S, Vijiaratnam N, Chan D W C, et al. Pain sensitivity in Parkinson's disease: systematic review and meta-analysis[J]. Parkinsonism Relat Disord, 2018, 48(3):17-27. doi: 10.1016/j.parkreldis.2017.12.031
[22]	Urwyler P, Nef T, Killen A, et al. Visual complaints and visual hallucinations in Parkinson's disease[J]. Parkinsonism Relat Disord, 2014, 20(3):318-322. doi: 10.1016/j.parkreldis.2013.12.009
[23]	Chen L, Yu C, Zhang N, et al. Cognitive impairment in patients with Parkinson's disease: a 30-month follow-up study[J]. Clin Neurol Neurosurg, 2016, 151(12):65-69. doi: 10.1016/j.clineuro.2016.09.021
[24]	Voon V, Napier T, Frank M, et al. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update[J]. Lancet Neurol, 2017, 16(3):238-250. doi: 10.1016/S1474-4422(17)30004-2
[25]	Baille G, Perez T, Devos D, et al. Early occurrence of inspiratory muscle weakness in Parkinson's disease[J]. PLoS One, 2018, 13(1):e0190400. doi: 10.1371/journal.pone.0190400
[26]	Baille G, de Jesus A M, Perez T, et al. Ventilatory dysfunction in Parkinson's disease[J]. J Parkinsons Dis, 2016, 6(3):463-471.
[27]	Torsney K M, Forsyth D. Respiratory dysfunction in Parkinson's disease[J]. J R Coll Physicians Edinb, 2017, 47(1):35-39. doi: 10.4997/JRCPE.2017.108 pmid: 28569280
[28]	Ding X, Gao J, Xie C, et al. Prevalence and clinical correlation of dysphagia in Parkinson disease: a study on Chinese patients[J]. Eur J Clin Nutr, 2018, 72(1):82-86. doi: 10.1038/ejcn.2017.100 pmid: 28699630
[29]	Mamolar Andres S, Santamarina Rabanal M L, Granda Membiela C M, et al. Swallowing disorders in Parkinson's disease[J]. Acta Otorrinolaringol Esp, 2017, 68(1):15-22. doi: S0001-6519(16)30010-3 pmid: 27269197
[30]	Wang M, Saasouh W, Botsford T, et al. Postoperative stridor and acute respiratory failure after Parkinson disease deep brain stimulator placement: case report and review of literature[J]. World Neurosurg, 2018, 111(3):22-25. doi: 10.1016/j.wneu.2017.11.176
[31]	Matheron D, Stathopoulos E T, Huber J E, et al. Laryngeal aerodynamics in healthy older adults and adults with Parkinson's disease[J]. J Speech Lang Hear Res, 2017, 60(3):507-524. doi: 10.1044/2016_JSLHR-S-14-0314
[32]	Troche M, Schumann B, Brandimore A, et al. Reflex cough and disease duration as predictors of swallowing dysfunction in Parkinson's disease[J]. Dysphagia, 2016, 31(6):757-764. doi: 10.1007/s00455-016-9734-6
[33]	van Hooren M R A, Baijens L W J, Voskuilen S, et al. Treatment effects for dysphagia in Parkinson's disease: a systematic review[J]. Parkinsonism Relat Disord, 2014, 20(8):800-807. doi: 10.1016/j.parkreldis.2014.03.026
[34]	Nobrega A C, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients?[J]. Parkinsonism Relat Disord, 2008, 14(8):646-648. doi: 10.1016/j.parkreldis.2007.12.007
[35]	Crosta F, Desideri G, Marini C. Obstructive sleep apnea syndrome in Parkinson's disease and other parkinsonisms[J]. Funct Neurol, 2017, 32(3):137-141. pmid: 29042002
[36]	da Silva-Junior F P, do Prado G F, Barbosa E R, et al. Sleep disordered breathing in Parkinson's disease: a critical appraisal[J]. Sleep Med Rev, 2014, 18(2):173-178. doi: 10.1016/j.smrv.2013.04.005 pmid: 23886661
[37]	Gunaydin Z Y, Ozer F F, Karagoz A, et al. Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment[J]. J Geriatr Cardiol, 2016, 13(1):75-80.
[38]	Fanciulli A, Strano S, Ndayisaba J P, et al. Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm[J]. J Neurol, 2014, 261(7):1291-1299. doi: 10.1007/s00415-014-7339-2
[39]	Velseboer D C, de Haan R J, Wieling W, et al. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis[J]. Parkinsonism Relat Disord, 2011, 17(10):724-729. doi: 10.1016/j.parkreldis.2011.04.016
[40]	Jost W H, Augustis S. Severity of orthostatic hypotension in the course of Parkinson's disease: no correlation with the duration of the disease[J]. Parkinsonism Relat Disord, 2015, 21(3):314-316. doi: 10.1016/j.parkreldis.2014.12.016
[41]	Iodice V, Low D A, Vichayanrat E, et al. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences[J]. J Neurol Sci, 2011, 310(1):133-138. doi: 10.1016/j.jns.2011.07.014
[42]	Bacchi S, Chim I, Kramer P, et al. Domperidone for hypotension in Parkinson's disease: a systematic review[J]. J Parkinsons Dis, 2017, 7(4):603-617.
[43]	Malek N, Grosset K, Stewart D, et al. Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease[J]. Parkinsonism Relat Disord, 2013, 19(6):586-589. doi: 10.1016/j.parkreldis.2013.02.004
[44]	Makaroff L, Gunn A, Gervasoni C, et al. Gastrointestinal disorders in Parkinson's disease: prevalence and health outcomes in a US claims database[J]. J Parkinsons Dis, 2011, 1(1):65-74.
[45]	Knudsen K, Szwebs M, Hansen A, et al. Gastric emptying in Parkinson's disease: a mini-review[J]. Parkinsonism Relat Disord, 2018, 55(10):18-25. doi: 10.1016/j.parkreldis.2018.06.003
[46]	Park H, Lee J Y, Shin C M, et al. Characterization of gastrointestinal disorders in patients with Parkinsonian syndromes[J]. Parkinsonism Relat Disord, 2015, 21(5):455-460. doi: 10.1016/j.parkreldis.2015.02.005
[47]	Vijverman A C, Fox S H. New treatments for the motor symptoms of Parkinson's disease[J]. Expert Rev Clin Pharmacol, 2014, 7(6):761-777. doi: 10.1586/17512433.2014.966812
[48]	Poewe W, Antonini A. Novel formulations and modes of delivery of levodopa[J]. Mov Disord, 2015, 30(1):114-120. doi: 10.1002/mds.v30.1
[49]	Anderson L, Fagerlund K. Original research: the perioperative experience of patients with Parkinson's disease: a qualitative study[J]. Am J Nurs, 2013, 113(2): 26-32, quiz 33. doi: 10.1097/01.NAJ.0000426686.84655.4a pmid: 23334560
[50]	Dhall R, Kreitzman D L. Advances in levodopa therapy for Parkinson disease: review of RYTARY (carbidopa and levodopa) clinical efficacy and safety[J]. Neurology, 2016, 86(14 Suppl 1):S13-S24. doi: 10.1212/WNL.0000000000002510
[51]	Salat D, Tolosa E. Levodopa in the treatment of Parkinson's disease: current status and new developments[J]. J Parkinsons Dis, 2013, 3(3):255-269.
[52]	Ward V. Anaesthesia for Caesarean section in a patient with Parkinson's disease[J]. Int J Obstet Anesth, 2018, 34:99-102. doi: S0959-289X(17)30191-7 pmid: 29352622
[53]	Thanacoody R. Serotonin syndrome[J]. Medicine, 2012, 40(2):63-64. doi: 10.1016/j.mpmed.2011.11.005
[54]	Arora A, Fletcher P. Parkinsonism hyperpyrexia syndrome caused by abrupt withdrawal of ropinirole[J]. Br J Hosp Med (Lond), 2013, 74(12):698-699. doi: 10.12968/hmed.2013.74.12.698
[55]	Oguz E, Ozturk I, Ozkan D, et al. Parkinson's disease and spinal anaesthesia[J]. Turk J Anaesthesiol Reanim, 2014, 42(5):280-282. doi: 10.5152/TJAR.
[56]	Gautam B, Baral B. Spinal anaesthesia for laparoscopic cholecystectomy in Parkinson's disease[J]. J Nepal Med Assoc, 2018, 56(211):701-704. pmid: 30381769
[57]	El-Refai N A. Anesthetic management for parturients with neurological disorders[J]. Anesth Essays Res, 2013, 7(2):147-154. doi: 10.4103/0259-1162.118940 pmid: 25885824
[58]	von Eckardstein K, Sixel-Döring F, Kazmaier S, et al. Asphyxia due to laryngeal spasm as a severe complication of awake deep brain stimulation for Parkinson's disease: a case report[J]. BMC Neurol, 2016, 16(1):216. pmid: 27821134
[59]	Fluchere F, Witjas T, Eusebio A, et al. Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2014, 85(10):1167-1173. doi: 10.1136/jnnp-2013-305323
[60]	Suttrup I, Warnecke T. Dysphagia in Parkinson's disease[J]. Dysphagia, 2016, 31(1):24-32. doi: 10.1007/s00455-015-9671-9 pmid: 26590572
[61]	Mastrangelo G, Comiati V, dell'Aquila M, et al. Exposure to anesthetic gases and Parkinson's disease: a case report[J]. BMC Neurol 2013, 13:194. doi: 10.1186/1471-2377-13-194 pmid: 24321326
[62]	Leikas J, Kohtala S, Theilmann W, et al. Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease[J]. J Neurochem, 2017, 142(3):456-463. doi: 10.1111/jnc.14066 pmid: 28488766
[63]	Shan Z, Cai S, Zhang T, et al. Effects of sevoflurane on leucine-rich repeat kinase 2-associated Drosophila model of Parkinson's disease[J]. Mol Med Rep, 2015, 11(3):2062-2070.
[64]	Burton D, Nicholson G, Hall G. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations[J]. Drugs Aging, 2004, 21(4):229-242. doi: 10.2165/00002512-200421040-00002
[65]	Wang S, Song T, Leng C, et al. Propofol protects against the neurotoxicity of 1‑methyl‑4‑phenylpyridinium[J]. Mol Med Rep, 2016, 13(1):309-314. doi: 10.3892/mmr.2015.4570
[66]	Sherer J, Salazar T, Schesing K, et al. Diphenhydramine for acute extrapyramidal symptoms after propofol administration[J]. Pediatrics, 2017, 139(2):e20161135. doi: 10.1542/peds.2016-1135
[67]	Xu X, Yu X, Wu X, et al. Propofol requirement for induction of unconsciousness is reduced in patients with Parkinson's disease: a case control study[J]. Biomed Res Int, 2015, 2015:953729.
[68]	Fan J C, Song J J, Wang Y, et al. Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson's disease[J]. Asian Pac J Trop Med, 2017, 10(10):1007-1010. doi: 10.1016/j.apjtm.2017.09.014
[69]	Vanle B, Olcott W, Jimenez J, et al. NMDA antagonists for treating the non-motor symptoms in Parkinson's disease[J]. Transl Psychiatry, 2018, 8(1):117. doi: 10.1038/s41398-018-0162-2
[70]	Wang J, Xu X, Yu X, et al. Remifentanil requirement for inhibiting responses to tracheal intubation and skin incision is reduced in patients with Parkinson's disease undergoing deep brain stimulator implantation[J]. J Neurosurg Anesthesiol, 2016, 28(4):303-308. doi: 10.1097/ANA.0000000000000229
[71]	Zesiewicz T, Hauser R, Freeman A, et al. Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease[J]. Clin Neuropharmacol, 2009, 32(1):48-50. doi: 10.1097/WNF.0b013e31817e23e3 pmid: 19471184
[72]	Kim W, Song I, Lim Y, et al. Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus[J]. J Korean Med Sci, 2014, 29(9):1278-1286. doi: 10.3346/jkms.2014.29.9.1278
[73]	Lee W, Ehm G, Yang H, et al. Bilateral deep brain stimulation of the subthalamic nucleus under sedation with propofol and fentanyl[J]. PLoS One, 2016, 11(3):e0152619. doi: 10.1371/journal.pone.0152619
[74]	El-Okdi N, Lumbrezer D, Karanovic D, et al. Serotonin syndrome after the use of tramadol and ziprasidone in a patient with a deep brain stimulator for Parkinson disease[J]. Am J Ther, 2014, 21(4):e97-99. doi: 10.1097/MJT.0b013e3182456d88
[75]	Aboukarr A, Giudice M. Interaction between monoamine oxidase B inhibitors and selective serotonin reuptake inhibitors[J]. Can J Hosp Pharm 2018, 71(3):196-207.
[76]	Bassani T, Vital M, Rauh L. Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs[J]. Arq Neuropsiquiatr, 2015, 73(7):616-623. doi: 10.1590/0004-282X20150057
[77]	Perez-Lloret S, Rey M, Dellapina E, et al. Emerging analgesic drugs for Parkinson's disease[J]. Expert Opin Emerg Drugs, 2012, 17(2):157-171. doi: 10.1517/14728214.2012.677949
[78]	Tampi R, Maksimowski M, Lingamchetty T, et al. Is ondansetron beneficial for psychosis associated with dementia?[J]. Ann Clin Psychiatry, 2018, 30(3):200-206.
[79]	Trevitt J, Vallance C, Harris A, et al. Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease[J]. Pharmacol Biochem Behav, 2009, 92(3):521-527. doi: 10.1016/j.pbb.2009.02.001
[80]	Renoux C, Dell'Aniello S, Khairy P, et al. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease[J]. Br J Clin Pharmacol, 2016, 82(2):461-472. doi: 10.1111/bcp.v82.2
[81]	Lertxundi U, Isla A, Solinís M, et al. Medication errors in Parkinson's disease inpatients in the Basque Country[J]. Parkinsonism Relat Disord, 2017, 36:57-62. doi: 10.1016/j.parkreldis.2016.12.028
[82]	Lubomski M, Rushworth R, Tisch S. Hospitalisation and comorbidities in Parkinson's disease: a large Australian retrospective study[J]. J Neurol Neurosurg Psychiatry, 2015, 86(3):324-330. doi: 10.1136/jnnp-2014-307822
[83]	Price C, Levy S, Tanner J, et al. Orthopedic surgery and post-operative cognitive decline in idiopathic Parkinson's disease: considerations from a pilot study[J]. J Parkinsons Dis, 2015, 5(4):893-905.
[84]	Gong G, Liu B, Wu J, et al. Postoperative cognitive dysfunction induced by different surgical methods and its risk factors[J]. Am Surg, 2018, 84(9):1531-1537.
[85]	Lertxundi U, Isla A, Solinís M Á, et al. Medication errors in Parkinson's disease inpatients in the Basque Country[J]. Parkinsonism Relat Disord, 2017, 36:57-62. doi: 10.1016/j.parkreldis.2016.12.028
[86]	Lennaerts H, Groot M, Rood B, et al. A Guideline for Parkinson's Disease Nurse Specialists, with Recommendations for Clinical Practice[J]. J Parkinsons Dis, 2017, 7(4):749-754.
[87]	Baker J F, McClelland S, Line B G, et al. In-hospital complications and resource utilization following lumbar spine surgery in patients with Parkinson disease: evaluation of the National Inpatient Sample Database[J]. World Neurosurg, 2017, 106:470-476. doi: 10.1016/j.wneu.2017.07.006
[88]	Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease[J]. Nat Rev Neurol, 2017, 13(4):217-231. doi: 10.1038/nrneurol.2017.27 pmid: 28257128
[89]	Pigott K, Rick J, Xie S X, et al. Longitudinal study of normal cognition in Parkinson disease[J]. Neurology, 2015, 85(15):1276-1282. doi: 10.1212/WNL.0000000000002001 pmid: 26362285
[90]	Furukawa S, Hirano S, Yamamoto T, et al. Decline in drawing ability and cerebral perfusion in Parkinson's disease patients after subthalamic nucleus deep brain stimulation surgery[J]. Parkinsonism Relat Disord, 2020, 70:60-66.
[91]	Kim M, Yoon J, Kim H, et al. Olfactory dysfunction is related to postoperative delirium in Parkinson's disease[J]. J Neural Transm (Vienna), 2016, 123(6):589-594.